Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab

• Igor Kos,
• Benedikt Balensiefer,
• Sophie Roth,
• Manfred Ahlgrimm,
• Martina Sester,
• Tina Schmidt,
• Lorenz Thurner,
• Moritz Bewarder,
• Robert Bals,
• Frank Lammert,
• Stephan Stilgenbauer,
• Dominic Kaddu-Mulindwa

Affiliations

Igor Kos

Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University, Homburg, Germany

Benedikt Balensiefer

Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University, Homburg, Germany

Sophie Roth

Department of Medical Microbiology and Hygiene, Institute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany

Manfred Ahlgrimm

Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University, Homburg, Germany

Martina Sester

Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany

Tina Schmidt

Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany

Lorenz Thurner

Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University, Homburg, Germany

Moritz Bewarder

Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University, Homburg, Germany

Robert Bals

Department of Pulmonology, Allergology and Critical Care Medicine, Saarland University, Homburg, Germany

Frank Lammert

Department of Gastroenterology, Hepatology, Endocrinology, Diabetology and Nutrition Medicine, Saarland University, Homburg, Germany

Stephan Stilgenbauer

Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University, Homburg, Germany

Dominic Kaddu-Mulindwa

Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University, Homburg, Germany